We have shown that the levels of these miRNAs may be associated with tumor size or the presence of lymph node metastases in breast cancer patients, but the presence of this association depends on the status and expression level of ER, PR, HER2, and Ki-67. This evidence concerns the gene MKI67 and breast carcinoma.